Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-07T13:51:28.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.7.0' is added to the study record history, updating the version history. The previous revision 'Revision: v3.6.6' is removed from the current view.
    Difference
    0.1%
    Check dated 2026-09-16T21:53:30.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-02T18:09:38.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The record history now lists a new revision (v3.6.5) that supersedes the previous version (v3.6.4).
    Difference
    0.1%
    Check dated 2026-08-12T09:00:02.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The record history now shows a new entry for Revision: v3.6.4, updating the page's revision metadata from v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-28T05:27:29.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The record history now includes a new version entry for v3.6.3 and removes the previous v3.6.2 entry, signaling an updated revision of the study record. This update documents the latest revision in the history.
    Difference
    0.1%
    Check dated 2026-07-06T16:41:11.000Z thumbnail image

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.